BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21627557)

  • 21. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
    Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A
    Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.
    Panidis D; Katsikis I; Karkanaki A; Piouka A; Armeni AK; Georgopoulos NA
    Med Hypotheses; 2011 Oct; 77(4):649-53. PubMed ID: 21807466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Ovarian Reserve Impacted in Anorexia Nervosa?
    Pitts S; Dahlberg SE; Gallagher JS; Gordon CM; DiVasta AD
    J Pediatr Adolesc Gynecol; 2021 Apr; 34(2):196-202. PubMed ID: 33278562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute onset of ovarian dysfunction in young females after start of cancer treatment.
    Mörse H; Elfving M; Lindgren A; Wölner-Hanssen P; Andersen CY; Øra I
    Pediatr Blood Cancer; 2013 Apr; 60(4):676-81. PubMed ID: 23015461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease.
    Saglam F; Onal ED; Ersoy R; Koca C; Ergin M; Erel O; Cakir B
    Gynecol Endocrinol; 2015 Feb; 31(2):165-8. PubMed ID: 25319839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.
    La Marca A; Marzotti S; Brozzetti A; Stabile G; Artenisio AC; Bini V; Giordano R; De Bellis A; Volpe A; Falorni A;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3816-23. PubMed ID: 19622621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibin B is lower and anti-Müllerian hormone is similar in serum of men with spinal cord injuries compared to controls.
    Ibrahim E; Aballa TC; Roudebush WE; Lynne CM; Brackett NL
    Syst Biol Reprod Med; 2015 Apr; 61(2):72-7. PubMed ID: 25581422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibin-producing ovarian granulosa cell tumor as a cause of secondary amenorrhea: case report and review of the literature.
    Kurihara S; Hirakawa T; Amada S; Ariyoshi K; Nakano H
    J Obstet Gynaecol Res; 2004 Dec; 30(6):439-43. PubMed ID: 15566459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Leptin and inhibin B as predictors of reproductive recovery in patients with anorexia nervosa during weight gain].
    Cetković A; Djurović M; Milić N
    Srp Arh Celok Lek; 2006; 134(11-12):492-7. PubMed ID: 17304762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortisol levels alter the response to metoclopramide in patients with hypothalamic amenorrhea.
    Mendes MC; Ferriani RA; Costa LO; Moura MD; Silva de Sá MF
    Gynecol Endocrinol; 1995 Mar; 9(1):9-14. PubMed ID: 7793305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic endocrine test of inhibin B and anti-Müllerian hormone in men with non-obstructive azoospermia.
    Tsametis C; Mintziori G; Iliadou PK; Tarlatzis BC; Papadimas I; Goulis DG
    Gynecol Endocrinol; 2011 Sep; 27(9):661-5. PubMed ID: 20923279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered serum profile of inhibin B, Pro-alphaC and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele.
    Trigo RV; Bergadá I; Rey R; Ballerini MG; Bedecarrás P; Bergadá C; Gottlieb S; Campo S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):758-64. PubMed ID: 15163341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?
    Torgac M; Kokcu A; Cetinkaya MB; Alper T; Malatyalioglu E
    Gynecol Endocrinol; 2005 Jun; 20(6):322-6. PubMed ID: 16019381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.